Lancet retracts and replaces news story about controversial abortion drug

The Lancet has retracted a journalist-written piece about a controversial drug used off-label to induce abortions, and replaced it with a corrected version.

In the retraction notice, the journal said it “removed the information that we believe to be inaccurate.”

The article, first published Oct. 28, 2017, highlights Pfizer’s decision to withdraw the drug, misoprostol, from the French market in 2018, and explores the ongoing debate surrounding its uses and safety. Approved to treat ulcers, misoprostol is more often used off-label to induce labor or medical abortions, despite reports of serious side effects, including hemorrhaging and birth defects “sometimes associated with fetal death.” Continue reading Lancet retracts and replaces news story about controversial abortion drug

Publisher issues first retractions for fake peer review, starts new checking policy

The publisher Frontiers has retracted four papers in three of its journals after discovering they had been accepted with fake peer reviews.

The problem of fake reviews has been on the research community’s radar since at least 2014, and several major publishers—including Springer, SAGE and BioMed Central—have retracted hundreds of papers accepted via fake peer reviews. But Gearóid Ó Faoleán, the ethics and integrity manager at Frontiers, told us this is the first time Frontiers had had to issue retractions for this reason.

The papers, published between 2015 and 2017, are from researchers based at the Council of Scientific & Industrial Research (CSIR)–National Institute for Interdisciplinary Science and Technology (NIIST) in Thiruvananthapuram, India. S. Nishanth Kumar is the only author in common to all four paper and a corresponding on two of them; Dileep Kumar, a scientist at CSIR, is a corresponding author on three of the papers.

Ó Faoleán told us: Continue reading Publisher issues first retractions for fake peer review, starts new checking policy

Director of U.S. HHS Office of Research Integrity temporarily removed from post

Kathy Partin

After a tumultuous two years, Kathy Partin is temporarily stepping away from her position as the director of the U.S. Office of Research Integrity.

According to an internal personnel announcement forwarded to us, on December 4, Partin will begin a 90-day stint at the Office of the Vice President for Research at the Uniformed Services University of the Health Sciences, which trains health professionals to support the U.S. military.

Partin declined to comment. A spokesperson for the Department of Health and Human Services (HHS), of which the Office of Research Integrity is a part, told us the agency cannot comment on personnel issues.

Linda Schutjer, a former colleague of Partin’s at Colorado State University, told us Partin was asked to leave:

Continue reading Director of U.S. HHS Office of Research Integrity temporarily removed from post

After losing two video game-violence papers, co-author’s weapons paper is flagged

Can seeing a weapon increase aggressive thoughts and behaviors?

A meta-analysis on the so-called “weapons effect” has been flagged with an expression of concern by a SAGE journal, after the researchers discovered errors affecting at least one of the main conclusions.

The paper found that the presence of weapons increased people’s aggressiveness, but not feelings of anger. However, the corresponding author, Arlin James Benjamin, who works at University of Arkansas–Fort Smith, told us:

we would urge considerably more caution in interpreting the impact of weapons on behavioral outcomes based on those initial re-analyses.

Last author Brad Bushman, a professor of communication and psychology at the Ohio State University (OSU), was the corresponding author on two now-retracted papers linking video games and violence. Continue reading After losing two video game-violence papers, co-author’s weapons paper is flagged

Weekend reads: Ethical issues could cost university millions in funding; Stolen bone raises questions; Ingelfinger rides again

The week at Retraction Watch featured a the story of how a nonexistent paper earned 400 ciations, a lawsuit filed against a journal for publishing criticism, and the retraction and replacement of a paper by a group of anti-vaccine advocates. Here’s what was happening elsewhere: Continue reading Weekend reads: Ethical issues could cost university millions in funding; Stolen bone raises questions; Ingelfinger rides again

PLOS ONE retracts two papers one year after author says he okayed the move

PLOS ONE has retracted two 2014 papers from a group of researchers, after an institutional investigation confirmed image duplication. Although the authors initially asked to correct the figures in the two papers, they ultimately agreed with the decision to retract.

Mrinal K. Maiti—an associate professor at the Indian Institute of Technology at Kharagpur and corresponding author on the two now-retracted PLOS ONE papers—also corrected a 2016 paper published in PLOS ONE over figure-related errors. Maiti is the only author in common to all papers.

A spokesperson for the journal told us:
 Continue reading PLOS ONE retracts two papers one year after author says he okayed the move

Caught Our Notice: “Profoundly sorry” researcher retracts Alzheimer’s-DDT paper

Via Wikimedia

Title: Immune response cytokines as potential biomarkers for DDT induced neurodegeneration

What Caught Our Attention:  Does exposure to pesticides such as DDT influence the onset of Alzheimer’s? Hard to say, especially after a researcher retracted a recent paper purporting to find a link in mice, a few months after a press release was issued about the work. The notice took on an unusual format — Continue reading Caught Our Notice: “Profoundly sorry” researcher retracts Alzheimer’s-DDT paper

WHO asks dozens of journals to correct papers on diagnostic tool developed by former collaborators

In one of the largest such requests we’ve ever heard of, the World Health Organization has asked 46 journals to correct articles that refer to a bone fracture risk diagnostic tool as developed or endorsed by the WHO.

By WHO’s count, the tool — known as Fracture Risk Assessment Tool (FRAX), which has come under scrutiny as experts have questioned its effectiveness — has been linked to the WHO in over 500 scientific articles. The organization wants to change that. The health agency says it has no ties to the tool and claims its developers have spread “misinformation” asserting a link to the WHO. But the tool’s lead developer disputes this, claiming the agency collaborated on the tool from its inception.

Last December, in an editorial published in the Bulletin of the World Health Organization titled “Clarifying WHO’s position on the FRAX tool for fracture prediction,” the organization disavowed a connection to the tool:

Continue reading WHO asks dozens of journals to correct papers on diagnostic tool developed by former collaborators

A physics journal agreed to retract a paper several months ago. It’s still not retracted.

A physics journal says it has planned for several months to retract a 2006 paper by a prominent researcher with multiple retractions, after a concerned reader notified the editor about extensive duplication.

But, more than seven months after receiving the complaint, the journal Thin Solid Films has not yet taken action.

So what’s taking so long?

According to the editor, Joseph Greene, the delay occurred because “the publication team missed the request.”

Duplication allegations have followed the paper’s corresponding author Naba K. Sahoo for the past few years. Sahoo, a top physicist in India, has already had seven papers retracted for duplication—five earlier this year (1, 2), and two last year.

Although we did not hear back from the journal or the publisher, Elsevier, forwarded email correspondence provide insights about the Thin Solid Films paper. Continue reading A physics journal agreed to retract a paper several months ago. It’s still not retracted.

Journal replaces anti-vaccine paper it retracted for missing conflicts, “number of errors”

A journal retracted a paper about how conflicts of interest might be influencing research into the link between vaccines and autism because — wait for it — the authors failed to disclose conflicts of interest.

According to the retraction notice, the editors retracted the paper without the authors’ agreement, because the authors had a host of personal and professional interests in the field they didn’t declare, such as being associated with organizations involved in autism and vaccine safety. What’s more, the article also contained “a number of errors, and mistakes of various types that raise concerns about the validity of the conclusion.”

But now, Science and Engineering Ethics has published a new version of the article that draws similar conclusions to the retracted one, albeit with an updated conflict of interest statement, among other changes. From the abstract of the revised version: Continue reading Journal replaces anti-vaccine paper it retracted for missing conflicts, “number of errors”